CD14 and metabolic syndrome: Moreover, both CCR5 and CCR2 expression levels correlate significantly with CD14+/CD16+ monocyte subset [36], and metabolic abnormalities such as dyslipidemia and insulin resistance, have been also reported to promote an inflammatory phenotype in circulating monocytes [37].